June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Parafoveal Cone Function in Choroideremia Assessed with Optoretinography
Author Affiliations & Notes
  • Peiluo Xu
    Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, United States
    Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Robert F Cooper
    Joint Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, Wisconsin, United States
    Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Yu You Jiang
    Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States
    Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Jessica Ijams Wolfing Morgan
    Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States
    Center for Advanced Retinal and Ocular Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Peiluo Xu None; Robert Cooper Translational Imaging Innovations, Code C (Consultant/Contractor), Translational Imaging Innovations, Code I (Personal Financial Interest), App. 16/389,942, Code P (Patent); Yu You Jiang None; Jessica Morgan AGTC, Code F (Financial Support), 8226236, Code P (Patent), App. 16/389,942, Code P (Patent)
  • Footnotes
    Support  NIH R01EY028601, NIH R01EY030227, NIH P30EY001583, Foundation Fighting Blindness, Research to Prevent Blindness, Center for Advanced Retinal and Ocular Therapeutics, F. M. Kirby Foundation, and the Paul and Evanina Bell Mackall Foundation Trust.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 472. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Peiluo Xu, Robert F Cooper, Yu You Jiang, Jessica Ijams Wolfing Morgan; Parafoveal Cone Function in Choroideremia Assessed with Optoretinography. Invest. Ophthalmol. Vis. Sci. 2023;64(8):472.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Choroideremia (CHM) is an X-linked retinal degeneration which causes progressive dysfunction of photoreceptors, retinal pigment epithelium, and choroid, ultimately leading to cell death and vision loss. The recent development of optoretinography allows non-invasive assessment of photoreceptor function. Here, we assess cone function in CHM using optoretinography.

Methods : The cone mosaic of 14 study participants (4 control, 10 CHM) were imaged 0.5-1° from the fovea using a custom-built, multimodal adaptive optics scanning light ophthalmoscope (795nm super luminescent diode imaging beam, 1°x1° field). Each imaging session consisted of 1-6 stimulus trials, and each trial included 1-13 video acquisitions. Non-stimulated trials were also collected. Subjects were dark adapted for 2 minutes prior to each trial. During each acquisition, a 2-second 450nW 550Δ10nm stimulus was presented to the subject 4 seconds after the recording started. Each video was registered, cones were identified, and the intensity of all cones throughout the videos were extracted, normalized, standardized, and aggregated over the cone mosaic to yield the population optoretinogram (ORG) as previously described (Cooper et al., 2017). A gamma probability density function was fit to the ORG and the peak of the fit within 6 seconds of stimulus onset was taken as the ORG amplitude. ORG amplitudes were compared between CHM and control participants using unbalanced one-way ANOVA. We correlated ORG amplitude with bound cone density and foveal sensitivity measured using the Nidek MP-1 microperimeter in CHM participants [Pearson correlation coefficient (PCC)].

Results : ORG amplitudes were significantly lower in CHM (mean ± standard deviation, 0.22±0.14, arbitrary units, range 0.04-0.48) compared to control (1.34±0.31, range 0.91-1.57, p<0.001). Cone density was reduced in CHM (53,900 ± 19,500 cones/mm2, control: 77,300 ± 8,800 cones/mm2, p=0.045). Microperimetry revealed constricted visual fields and reduced retinal sensitivities in CHM. CHM ORG amplitude was positively correlated with cone density (PCC=0.69) and foveal sensitivity (PCC=0.73).

Conclusions : Parafoveal cone function is reduced in CHM patients despite the tested locations remaining within the centrally intact retinal area. The correlation between ORG amplitude and retinal sensitivity shows promise for using ORG as an objective biomarker of photoreceptor function in disease.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×